| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.40e-04 | 3 | 137 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | RNA polymerase I core binding | 2.78e-04 | 4 | 137 | 2 | GO:0001042 | |
| GeneOntologyMolecularFunction | SUMO binding | 2.82e-04 | 19 | 137 | 3 | GO:0032183 | |
| GeneOntologyMolecularFunction | proteasome binding | 3.31e-04 | 20 | 137 | 3 | GO:0070628 | |
| GeneOntologyBiologicalProcess | organelle localization | VPS11 MYO1A MYO5A MYO5B SYNE1 KIFAP3 STX3 CEP120 MDN1 FHOD1 AP3B2 EXOC6B DNM3 ATM UXT CADPS2 DYNC1H1 HTT | 1.10e-06 | 703 | 138 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | CHERP MYO5A SYNE1 DZIP1 ITPR2 ITPR3 VPS13D ANKRD13C NOS1 HTT SORL1 | 1.40e-06 | 259 | 138 | 11 | GO:0051651 |
| GeneOntologyBiologicalProcess | positive regulation of cilium assembly | 3.44e-06 | 35 | 138 | 5 | GO:0045724 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYO5A MYO5B SYNE1 KIFAP3 CEP120 MDN1 FHOD1 AP3B2 EXOC6B DNM3 ATM UXT CADPS2 DYNC1H1 HTT | 3.96e-06 | 546 | 138 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | PLXNA3 SETX MYO5B KALRN RRN3P2 DZIP1 ASAP1 CEP120 UBE2V2 RRN3 WRAP73 DNM3 PLXNA1 HTT | 5.95e-06 | 494 | 138 | 14 | GO:0031346 |
| GeneOntologyBiologicalProcess | intracellular transport | VPS11 NUP107 MYO5A MYO5B ABCA12 SYNE1 XPO4 KIFAP3 MALT1 VPS13D STX3 IPO9 ADRB2 DST CEP120 MDN1 FHOD1 AP3B2 VPS41 EXOC6B UXT HERC2 DYNC1H1 HTT UEVLD SORL1 | 5.98e-06 | 1496 | 138 | 26 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | VPS11 HAUS6 MYO5B SYNE1 HJURP ARHGEF18 DZIP1 ASAP1 CEP120 SACS UBE2V2 FHOD1 VPS41 WRAP73 DNM3 SENP6 ATM DYNC1H1 TBCD HTT AMIGO2 SORL1 | 1.33e-05 | 1189 | 138 | 22 | GO:0044087 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 1.83e-05 | 278 | 138 | 10 | GO:0031503 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 1.94e-05 | 280 | 138 | 10 | GO:1902115 | |
| GeneOntologyBiologicalProcess | vesicle localization | 4.39e-05 | 247 | 138 | 9 | GO:0051648 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 4.44e-05 | 2 | 138 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle assembly | 4.82e-05 | 97 | 138 | 6 | GO:1902117 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 5.11e-05 | 98 | 138 | 6 | GO:0008088 | |
| GeneOntologyBiologicalProcess | maintenance of location | CHERP MYO5A SYNE1 DZIP1 ITPR2 ITPR3 VPS13D ANKRD13C NOS1 HTT SORL1 | 7.40e-05 | 396 | 138 | 11 | GO:0051235 |
| GeneOntologyBiologicalProcess | nuclear migration | 7.61e-05 | 34 | 138 | 4 | GO:0007097 | |
| GeneOntologyBiologicalProcess | vesicle cytoskeletal trafficking | 8.63e-05 | 67 | 138 | 5 | GO:0099518 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 8.80e-05 | 108 | 138 | 6 | GO:1902017 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | PLXNA3 SETX MYO5B KALRN SYNE1 RRN3P2 DZIP1 ASAP1 VPS13D ADRB2 CEP120 UBE2V2 RRN3 FHOD1 WRAP73 DNM3 ATM PLXNA1 DYNC1H1 HTT AMIGO2 PROS1 | 1.07e-04 | 1366 | 138 | 22 | GO:0051130 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.09e-04 | 217 | 138 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.33e-04 | 3 | 138 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 1.35e-04 | 224 | 138 | 8 | GO:0051650 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 1.39e-04 | 225 | 138 | 8 | GO:0030705 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in cell | 1.57e-04 | 76 | 138 | 5 | GO:0032507 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 1.80e-04 | 123 | 138 | 6 | GO:0120034 | |
| GeneOntologyBiologicalProcess | nucleus localization | 2.12e-04 | 44 | 138 | 4 | GO:0051647 | |
| GeneOntologyBiologicalProcess | macroautophagy | 2.16e-04 | 374 | 138 | 10 | GO:0016236 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 HAUS6 DZIP1 DDB1 FSIP2 DST CEP120 WRAP73 SENP6 UXT DYNC1H1 TBCD HTT WDR72 | 3.42e-04 | 720 | 138 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | protein localization to organelle | VPS11 NUP107 KALRN SYNE1 SRP68 SRP72 PCARE DZIP1 ASAP1 FSIP2 VPS13D IPO9 ANKRD13C VPS41 PARP9 IK HTT SORL1 | 3.60e-04 | 1091 | 138 | 18 | GO:0033365 |
| GeneOntologyBiologicalProcess | transport along microtubule | 3.68e-04 | 197 | 138 | 7 | GO:0010970 | |
| GeneOntologyBiologicalProcess | regulation of mini excitatory postsynaptic potential | 4.39e-04 | 5 | 138 | 2 | GO:0061884 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.39e-04 | 5 | 138 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | mini excitatory postsynaptic potential | 4.39e-04 | 5 | 138 | 2 | GO:0098816 | |
| GeneOntologyBiologicalProcess | positive regulation of lipophagy | 4.39e-04 | 5 | 138 | 2 | GO:1904504 | |
| GeneOntologyBiologicalProcess | regulation of lipophagy | 4.39e-04 | 5 | 138 | 2 | GO:1904502 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | VPS11 NUP107 MYO5A MYO5B ABCA12 XPO4 VPS13D STX3 IPO9 AP3B2 VPS41 EXOC6B HERC2 SORL1 | 4.49e-04 | 740 | 138 | 14 | GO:0006886 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.53e-04 | 146 | 138 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 4.70e-04 | 147 | 138 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 5.05e-04 | 149 | 138 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | MYO5B DZIP1 ASAP1 CEP120 UBE2V2 FHOD1 WRAP73 DNM3 ATM DYNC1H1 HTT AMIGO2 | 5.49e-04 | 582 | 138 | 12 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | PLXNA3 SETX MYO5B KALRN SYNE1 RRN3P2 DZIP1 ASAP1 CEP120 UBE2V2 RRN3 WRAP73 DNM3 PLXNA1 HTT | 5.51e-04 | 846 | 138 | 15 | GO:0120035 |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.80e-04 | 153 | 138 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | PLXNA3 SETX MYO5B KALRN SYNE1 RRN3P2 DZIP1 ASAP1 CEP120 UBE2V2 RRN3 WRAP73 DNM3 PLXNA1 HTT | 6.76e-04 | 863 | 138 | 15 | GO:0031344 |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 HAUS6 MYO5A DZIP1 DDB1 FSIP2 KIFAP3 DST CEP120 AP3B2 WRAP73 SENP6 UXT DYNC1H1 TBCD HTT WDR72 | 7.13e-04 | 1058 | 138 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | neuron development | SLC25A46 PLXNA3 SETX RPS6KA5 MYO5B KALRN SYNE1 LAMA2 RRN3P2 PCARE ASAP1 POSTN STX3 DST UBE2V2 RRN3 DNM3 TRPM1 PLXNA1 TBCD HTT | 7.24e-04 | 1463 | 138 | 21 | GO:0048666 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.24e-05 | 78 | 137 | 6 | GO:0001917 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | UBR2 FBXL13 PRAMEF5 SESN3 DZIP1 REV3L ECPAS DDB1 CNOT8 MALT1 ZZZ3 PSME4 UBE2V2 DDA1 CNOT7 UXT FBXO32 PRAMEF6 NAA16 | 1.96e-05 | 972 | 137 | 19 | GO:0140535 |
| GeneOntologyCellularComponent | AP-3 adaptor complex | 7.51e-05 | 13 | 137 | 3 | GO:0030123 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYO1A MYO5A MYO5B KALRN SYNE1 LAMA2 ASAP1 ITPR3 SNX14 STX3 ADRB2 SACS DNM3 CCR1 TRPM1 NOS1 DYNC1H1 HTT HDAC1 SORL1 | 1.49e-04 | 1228 | 137 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | CCR4-NOT core complex | 6.29e-04 | 6 | 137 | 2 | GO:0030015 | |
| GeneOntologyCellularComponent | axon | SETX MYO1A MYO5A ITPR2 STX3 ADRB2 DST SACS AP3B2 DNM3 TRPM1 NOS1 DYNC1H1 UNC80 HTT | 7.57e-04 | 891 | 137 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 8.26e-04 | 111 | 137 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | postsynapse | MYO5A MYO5B KALRN SYNE1 LAMA2 ASAP1 KIFAP3 SNX14 STX3 ADRB2 DST DNM3 SENP6 CADPS2 NOS1 HTT | 1.04e-03 | 1018 | 137 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | dendritic spine | 1.10e-03 | 242 | 137 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.24e-03 | 247 | 137 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.49e-03 | 9 | 137 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | dendrite | MYO5A MYO5B SYNE1 LAMA2 ASAP1 ITPR3 SNX14 STX3 ADRB2 SACS DNM3 TRPM1 NOS1 HTT | 1.53e-03 | 858 | 137 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYO5A MYO5B SYNE1 LAMA2 ASAP1 ITPR3 SNX14 STX3 ADRB2 SACS DNM3 TRPM1 NOS1 HTT | 1.56e-03 | 860 | 137 | 14 | GO:0097447 |
| MousePheno | abnormal Purkinje cell dendrite morphology | 5.70e-06 | 58 | 109 | 6 | MP:0008572 | |
| MousePheno | abnormal neurite morphology | SLC25A46 RPS6KA5 MYO5A KALRN ECPAS ADGRG6 DST SACS LTN1 ATM HERC2 CADPS2 NOS1 HTT | 8.39e-06 | 442 | 109 | 14 | MP:0008415 |
| MousePheno | impaired limb coordination | 9.41e-05 | 59 | 109 | 5 | MP:0001524 | |
| MousePheno | abnormal neuromuscular synapse morphology | 9.69e-05 | 95 | 109 | 6 | MP:0001053 | |
| MousePheno | abnormal dendrite morphology | 9.73e-05 | 237 | 109 | 9 | MP:0008143 | |
| MousePheno | abnormal somatic motor system morphology | 1.15e-04 | 98 | 109 | 6 | MP:0001051 | |
| Domain | ARM-type_fold | VPS11 XPO4 ECPAS VIRMA ITPR2 KIFAP3 IPO9 PSME4 FHOD1 AP3B2 LTN1 MROH7 ATM TBCD HTT | 2.42e-08 | 339 | 135 | 15 | IPR016024 |
| Domain | ARM-like | SETX XPO4 ECPAS KIFAP3 IPO9 PSME4 FHOD1 AP3B2 LTN1 MROH7 TBCD HTT | 6.24e-07 | 270 | 135 | 12 | IPR011989 |
| Domain | - | 4.96e-06 | 222 | 135 | 10 | 1.25.10.10 | |
| Domain | RNaseH-like_dom | 1.42e-04 | 69 | 135 | 5 | IPR012337 | |
| Domain | HEAT_REPEAT | 1.52e-04 | 70 | 135 | 5 | PS50077 | |
| Domain | InsP3_rcpt-bd | 1.55e-04 | 3 | 135 | 2 | IPR000493 | |
| Domain | - | 3.66e-04 | 47 | 135 | 4 | 3.30.420.10 | |
| Domain | Myosin_S1_N | 5.11e-04 | 5 | 135 | 2 | IPR008989 | |
| Domain | RNase_CAF1 | 5.11e-04 | 5 | 135 | 2 | IPR006941 | |
| Domain | CAF1 | 5.11e-04 | 5 | 135 | 2 | PF04857 | |
| Domain | Spectrin | 5.88e-04 | 23 | 135 | 3 | PF00435 | |
| Domain | WGR_domain | 6.69e-04 | 24 | 135 | 3 | IPR008893 | |
| Domain | RIH_assoc-dom | 7.63e-04 | 6 | 135 | 2 | IPR013662 | |
| Domain | Dilute_dom | 7.63e-04 | 6 | 135 | 2 | IPR002710 | |
| Domain | Ins145_P3_rec | 7.63e-04 | 6 | 135 | 2 | PF08709 | |
| Domain | DIL | 7.63e-04 | 6 | 135 | 2 | PF01843 | |
| Domain | RIH_assoc | 7.63e-04 | 6 | 135 | 2 | PF08454 | |
| Domain | RIH_dom | 7.63e-04 | 6 | 135 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.63e-04 | 6 | 135 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.63e-04 | 6 | 135 | 2 | IPR015925 | |
| Domain | - | 7.63e-04 | 6 | 135 | 2 | 1.25.10.30 | |
| Domain | DILUTE | 7.63e-04 | 6 | 135 | 2 | PS51126 | |
| Domain | RYDR_ITPR | 7.63e-04 | 6 | 135 | 2 | PF01365 | |
| Domain | DIL | 7.63e-04 | 6 | 135 | 2 | SM01132 | |
| Domain | - | 7.77e-04 | 207 | 135 | 7 | 1.25.40.10 | |
| Domain | - | 8.50e-04 | 26 | 135 | 3 | 4.10.60.10 | |
| Domain | Clathrin | 1.06e-03 | 7 | 135 | 2 | PF00637 | |
| Domain | CHCR | 1.06e-03 | 7 | 135 | 2 | PS50236 | |
| Domain | Spectrin_repeat | 1.18e-03 | 29 | 135 | 3 | IPR002017 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.41e-03 | 8 | 135 | 2 | IPR000547 | |
| Domain | TPR-like_helical_dom | 1.54e-03 | 233 | 135 | 7 | IPR011990 | |
| Domain | SPEC | 1.57e-03 | 32 | 135 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.57e-03 | 32 | 135 | 3 | IPR018159 | |
| Domain | Plexin_cytopl | 1.81e-03 | 9 | 135 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.81e-03 | 9 | 135 | 2 | IPR013548 | |
| Domain | Plexin | 1.81e-03 | 9 | 135 | 2 | IPR031148 | |
| Domain | ZF_CCHC | 2.04e-03 | 35 | 135 | 3 | PS50158 | |
| Domain | MIR | 2.25e-03 | 10 | 135 | 2 | PF02815 | |
| Domain | MIR_motif | 2.25e-03 | 10 | 135 | 2 | IPR016093 | |
| Domain | MIR | 2.25e-03 | 10 | 135 | 2 | PS50919 | |
| Domain | MIR | 2.25e-03 | 10 | 135 | 2 | SM00472 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 2.25e-03 | 10 | 135 | 2 | IPR001709 | |
| Domain | Myosin_head_motor_dom | 2.59e-03 | 38 | 135 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.59e-03 | 38 | 135 | 3 | PS51456 | |
| Domain | Myosin_head | 2.59e-03 | 38 | 135 | 3 | PF00063 | |
| Domain | MYSc | 2.59e-03 | 38 | 135 | 3 | SM00242 | |
| Domain | PNMA | 2.73e-03 | 11 | 135 | 2 | IPR026523 | |
| Domain | Laminin_G_1 | 2.73e-03 | 11 | 135 | 2 | PF00054 | |
| Domain | PNMA | 2.73e-03 | 11 | 135 | 2 | PF14893 | |
| Domain | OxRdtase_FAD/NAD-bd | 3.26e-03 | 12 | 135 | 2 | IPR001433 | |
| Domain | NAD_binding_1 | 3.26e-03 | 12 | 135 | 2 | PF00175 | |
| Domain | ATPase_dyneun-rel_AAA | 4.46e-03 | 14 | 135 | 2 | IPR011704 | |
| Domain | AAA_5 | 4.46e-03 | 14 | 135 | 2 | PF07728 | |
| Domain | HEAT | 5.04e-03 | 48 | 135 | 3 | PF02985 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 6.57e-03 | 17 | 135 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 6.57e-03 | 17 | 135 | 2 | PS51059 | |
| Domain | PARP | 6.57e-03 | 17 | 135 | 2 | PF00644 | |
| Domain | - | 6.57e-03 | 17 | 135 | 2 | 3.90.228.10 | |
| Pubmed | CHERP ACACA NUP107 MYO5A SRP68 SRP72 ECPAS VIRMA DDB1 ITPR3 DST MDN1 ATM HERC2 IK DYNC1H1 | 8.90e-09 | 653 | 139 | 16 | 22586326 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 SETX ACACA SRP68 PCARE SAMHD1 LRRC70 REV3L ECPAS ITPR2 ZZZ3 DST MDN1 ATM DYNC1H1 HDAC1 | 4.66e-08 | 736 | 139 | 16 | 29676528 |
| Pubmed | Nucleolar stress controls mutant Huntington toxicity and monitors Huntington's disease progression. | 6.25e-08 | 3 | 139 | 3 | 34880223 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | HAUS6 NUP107 MYO5B XPO4 SRP68 PCARE CCDC51 POSTN KIFAP3 IPO9 CEP120 UBE2V2 DDA1 CNOT7 EXOC6B TFB2M UXT DYNC1H1 TBCD HDAC1 SORL1 | 7.11e-08 | 1321 | 139 | 21 | 27173435 |
| Pubmed | 9.23e-08 | 92 | 139 | 7 | 20301317 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.15e-07 | 104 | 139 | 7 | 31240132 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.66e-06 | 202 | 139 | 8 | 33005030 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.37e-06 | 212 | 139 | 8 | 33853758 | |
| Pubmed | HAUS6 NUP107 ECPAS DDB1 IPO9 CEP120 CNOT7 LTN1 IK DYNC1H1 TBCD HDAC1 | 2.82e-06 | 560 | 139 | 12 | 35241646 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FBXL13 PRAMEF5 MYO5A DDB1 ZBED5 VPS13D IPO9 PSME4 FHOD1 LTN1 EXOC6B PRAMEF6 | 3.04e-06 | 564 | 139 | 12 | 21565611 |
| Pubmed | 3.39e-06 | 101 | 139 | 6 | 9872452 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HAUS6 CHERP RETREG2 NUP107 SYNE1 HJURP DDB1 CNOT8 CEP120 DDA1 CNOT7 WRAP73 ATM HERC2 DYNC1H1 TBCD NAA16 | 3.93e-06 | 1155 | 139 | 17 | 20360068 |
| Pubmed | LURAP1 ZCCHC12 MYO5A KALRN SYNE1 SESN3 DZIP1 REV3L ZBED5 CNOT8 DST SACS DNM3 SENP6 ATM HERC2 CADPS2 DYNC1H1 | 3.96e-06 | 1285 | 139 | 18 | 35914814 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SETX CHERP NUP107 SRP68 SRP72 DDB1 IPO9 MDN1 FHOD1 ATM IK DYNC1H1 | 4.18e-06 | 582 | 139 | 12 | 20467437 |
| Pubmed | 4.92e-06 | 234 | 139 | 8 | 36243803 | ||
| Pubmed | UBR2 NUP107 MYO5A MYO5B XPO4 ASAP1 ITPR2 ITPR3 POSTN CNNM3 IPO9 LTN1 UXT UTP3 HERC2 IK | 4.94e-06 | 1049 | 139 | 16 | 27880917 | |
| Pubmed | 7.98e-06 | 250 | 139 | 8 | 33536335 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 ACACA KALRN REV3L ITPR2 ITPR3 DST MDN1 PSME4 HERC2 PLXNA1 DYNC1H1 CYB5R2 TBCD HTT BAHCC1 | 9.45e-06 | 1105 | 139 | 16 | 35748872 |
| Pubmed | Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis. | 1.59e-05 | 2 | 139 | 2 | 12015311 | |
| Pubmed | The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival. | 1.59e-05 | 2 | 139 | 2 | 29789657 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22340173 | ||
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 1.59e-05 | 2 | 139 | 2 | 9065779 | |
| Pubmed | Conservation of the deadenylase activity of proteins of the Caf1 family in human. | 1.59e-05 | 2 | 139 | 2 | 15769875 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25540325 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18029446 | ||
| Pubmed | A neuroprotective phase precedes striatal degeneration upon nucleolar stress. | 1.59e-05 | 2 | 139 | 2 | 23764776 | |
| Pubmed | Structural insights into DDA1 function as a core component of the CRL4-DDB1 ubiquitin ligase. | 1.59e-05 | 2 | 139 | 2 | 30564455 | |
| Pubmed | Human apo-SRP72 and SRP68/72 complex structures reveal the molecular basis of protein translocation. | 1.59e-05 | 2 | 139 | 2 | 28369529 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16672232 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 1.59e-05 | 2 | 139 | 2 | 8081734 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9285789 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38745938 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27928163 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8413268 | ||
| Pubmed | Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. | 1.59e-05 | 2 | 139 | 2 | 28017939 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30918302 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15632133 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34042275 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8401589 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27257073 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24277524 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12620228 | ||
| Pubmed | Proteasome-Associated Proteins, PA200 and ECPAS, Are Essential for Murine Spermatogenesis. | 1.59e-05 | 2 | 139 | 2 | 37189334 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10531300 | ||
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 1.59e-05 | 2 | 139 | 2 | 17496801 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17254600 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 1.59e-05 | 2 | 139 | 2 | 24901844 | |
| Pubmed | Assembly of the 68- and 72-kD proteins of signal recognition particle with 7S RNA. | 1.59e-05 | 2 | 139 | 2 | 8388879 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33854148 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19528657 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8063813 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9399828 | ||
| Pubmed | CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex. | 1.59e-05 | 2 | 139 | 2 | 35248544 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31110473 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19605561 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23393135 | ||
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 1.59e-05 | 2 | 139 | 2 | 16195467 | |
| Pubmed | Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons. | 1.59e-05 | 2 | 139 | 2 | 24273493 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15713744 | ||
| Pubmed | Chronic stress promotes gastric cancer progression via the adrenoceptor beta 2/PlexinA1 pathway. | 1.59e-05 | 2 | 139 | 2 | 38331165 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25695270 | ||
| Pubmed | The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin. | 1.59e-05 | 2 | 139 | 2 | 33233776 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHERP NUP107 MYO5A MYO5B SYNE1 DDB1 ITPR2 ITPR3 CNNM3 DST MDN1 SACS HERC2 IK DYNC1H1 | 1.60e-05 | 1024 | 139 | 15 | 24711643 |
| Pubmed | CHERP NUP107 MYO5A TTPAL ECPAS ITPR2 ITPR3 CNNM3 IPO9 MDN1 PARP16 FHOD1 CNOT7 PARP9 HERC2 DYNC1H1 | 1.86e-05 | 1168 | 139 | 16 | 19946888 | |
| Pubmed | 2.20e-05 | 14 | 139 | 3 | 8022818 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX ACACA NUP107 MYO5A SRP68 DDB1 ZBED5 ASAP1 IPO9 DST MDN1 PSME4 FHOD1 LTN1 HERC2 IK DYNC1H1 | 3.01e-05 | 1353 | 139 | 17 | 29467282 |
| Pubmed | 3.34e-05 | 497 | 139 | 10 | 23414517 | ||
| Pubmed | 3.39e-05 | 151 | 139 | 6 | 17043677 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 3.54e-05 | 400 | 139 | 9 | 35013556 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.99e-05 | 313 | 139 | 8 | 38270169 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO5A MYO5B SRP68 SRP72 VIRMA DDB1 ITPR2 ITPR3 DST FHOD1 TFB2M UTP3 IK PATJ DYNC1H1 HDAC1 | 4.50e-05 | 1257 | 139 | 16 | 36526897 |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 10874040 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 20395455 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 17437169 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 28939769 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 18547250 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 36350267 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 11413485 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26009177 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 36951067 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 28202763 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 24508725 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 4.75e-05 | 3 | 139 | 2 | 1693919 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 23955339 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 31979185 | ||
| Pubmed | Structural basis of lentiviral subversion of a cellular protein degradation pathway. | 4.75e-05 | 3 | 139 | 2 | 24336198 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 23048028 | ||
| Pubmed | The CCR4-NOT complex suppresses untimely translational activation of maternal mRNAs. | 4.75e-05 | 3 | 139 | 2 | 37767629 | |
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 4.75e-05 | 3 | 139 | 2 | 24904548 | |
| Pubmed | Structural insights into the globular tails of the human type v myosins Myo5a, Myo5b, And Myo5c. | 4.75e-05 | 3 | 139 | 2 | 24339992 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 4.75e-05 | 3 | 139 | 2 | 9858485 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 33021411 | ||
| Pubmed | Histone deacetylase regulation of ATM-mediated DNA damage signaling. | 4.75e-05 | 3 | 139 | 2 | 23939379 | |
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 4.75e-05 | 3 | 139 | 2 | 21435446 | |
| Pubmed | A novel form of capsaicin-modified amygdala LTD mediated by TRPM1. | 4.75e-05 | 3 | 139 | 2 | 27633915 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 9808793 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 8806646 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 18194433 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 19217408 | ||
| Pubmed | The temporal and spatial expression pattern of myosin Va, Vb and VI in the mouse ovary. | 4.75e-05 | 3 | 139 | 2 | 16713372 | |
| Interaction | GPR17 interactions | SLC25A46 SETX RETREG2 XPO4 ECPAS ITPR2 MDN1 SACS LTN1 ATM TBCD HTT | 3.64e-07 | 283 | 132 | 12 | int:GPR17 |
| Interaction | NPTN interactions | 2.24e-06 | 278 | 132 | 11 | int:NPTN | |
| Interaction | ZDBF2 interactions | 3.21e-06 | 62 | 132 | 6 | int:ZDBF2 | |
| Interaction | MRFAP1L1 interactions | 9.02e-06 | 112 | 132 | 7 | int:MRFAP1L1 | |
| Interaction | C3orf18 interactions | 1.07e-05 | 115 | 132 | 7 | int:C3orf18 | |
| Interaction | SIRT7 interactions | CHERP ACACA NUP107 MYO5A SRP68 SRP72 ECPAS VIRMA DDB1 ITPR3 DST MDN1 ATM HERC2 IK DYNC1H1 | 2.96e-05 | 744 | 132 | 16 | int:SIRT7 |
| Interaction | PSMD2 interactions | ACACA SAMHD1 ECPAS VIRMA IPO9 ADRB2 PSME4 WRAP73 FBXO32 HERC2 HTT HDAC1 | 2.97e-05 | 435 | 132 | 12 | int:PSMD2 |
| Interaction | ZNF827 interactions | 3.68e-05 | 29 | 132 | 4 | int:ZNF827 | |
| Interaction | SCN2B interactions | 3.80e-05 | 95 | 132 | 6 | int:SCN2B | |
| Interaction | AXDND1 interactions | 4.36e-05 | 11 | 132 | 3 | int:AXDND1 | |
| Interaction | LRRC31 interactions | 6.27e-05 | 205 | 132 | 8 | int:LRRC31 | |
| Interaction | CTDP1 interactions | 6.71e-05 | 207 | 132 | 8 | int:CTDP1 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 8.34e-05 | 3 | 96 | 2 | 297 | |
| GeneFamily | Myosins, class V | 8.34e-05 | 3 | 96 | 2 | 1100 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 3.07e-04 | 25 | 96 | 3 | 74 | |
| GeneFamily | Plexins | 9.80e-04 | 9 | 96 | 2 | 683 | |
| GeneFamily | Paraneoplastic Ma antigens | 1.49e-03 | 11 | 96 | 2 | 671 | |
| GeneFamily | CCR4-NOT transcription complex | 1.49e-03 | 11 | 96 | 2 | 1023 | |
| GeneFamily | Gla domain containing | 2.09e-03 | 13 | 96 | 2 | 1250 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.60e-03 | 17 | 96 | 2 | 684 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.04e-03 | 18 | 96 | 2 | 91 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | INTS6L UBR2 VPS11 HAUS6 SETX RPS6KA5 MYO5A SYNE1 SESN3 XPO4 REV3L ZBED5 ASAP1 ITPR2 MALT1 SACS FHOD1 SENP6 PARP9 ATM IK DYNC1H1 TBCD SORL1 | 8.05e-07 | 1492 | 137 | 24 | M40023 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SLC25A46 UBR2 VPS11 SETX ACACA RETREG2 ECPAS ITPR2 MALT1 ADRB2 MDN1 SACS RRN3 LTN1 VPS41 SENP6 CCR1 ATM DYNC1H1 AMIGO2 UEVLD | 1.40e-06 | 1215 | 137 | 21 | M41122 |
| Coexpression | GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP | 1.08e-05 | 200 | 137 | 8 | M6927 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 2.89e-05 | 167 | 137 | 7 | M361 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HAUS6 SETX MYO5A DZIP1 REV3L ITPR2 ZZZ3 SACS VPS41 TRPM1 ATM PROS1 SORL1 | 4.20e-05 | 656 | 137 | 13 | M18979 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 5.35e-05 | 184 | 137 | 7 | M9005 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PLXNA3 PRAMEF5 MYO5B KALRN SYNE1 SESN3 DZIP1 ECPAS ASAP1 ITPR2 DST DNM3 FBXO32 PRAMEF6 HTT PROS1 SORL1 | 8.21e-05 | 1124 | 137 | 17 | MM1070 |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 8.75e-05 | 199 | 137 | 7 | M316 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_DN | 8.75e-05 | 199 | 137 | 7 | M7036 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 8.75e-05 | 199 | 137 | 7 | M9178 | |
| Coexpression | GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP | 8.75e-05 | 199 | 137 | 7 | M6934 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 8.99e-05 | 86 | 137 | 5 | M39247 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP | 9.03e-05 | 200 | 137 | 7 | M7077 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 9.03e-05 | 200 | 137 | 7 | M7441 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 9.03e-05 | 200 | 137 | 7 | M9133 | |
| Coexpression | GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN | 1.17e-04 | 145 | 137 | 6 | M359 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-06 | 190 | 138 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-06 | 190 | 138 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.26e-06 | 191 | 138 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.77e-06 | 197 | 138 | 7 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 2.77e-06 | 197 | 138 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 198 | 138 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.96e-06 | 199 | 138 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.96e-06 | 199 | 138 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.96e-06 | 155 | 138 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.37e-05 | 167 | 138 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.57e-05 | 171 | 138 | 6 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.84e-05 | 176 | 138 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.90e-05 | 177 | 138 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.90e-05 | 177 | 138 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-05 | 178 | 138 | 6 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 181 | 138 | 6 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 2.16e-05 | 181 | 138 | 6 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 2.23e-05 | 182 | 138 | 6 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 188 | 138 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.75e-05 | 189 | 138 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.75e-05 | 189 | 138 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.84e-05 | 190 | 138 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.01e-05 | 192 | 138 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | droplet-Lung-30m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-05 | 192 | 138 | 6 | 452d54f0aca8657722d7ac61e8422921d08c06b3 | |
| ToppCell | droplet-Lung-30m-Endothelial-venous_endothelial-vein_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-05 | 192 | 138 | 6 | 7ddaca206599603d4d0b2afb73ed2850225d277d | |
| ToppCell | droplet-Lung-30m-Endothelial-venous_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-05 | 192 | 138 | 6 | bf0b996aeedc34a79c71df3379ec9c1aabe06a8c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.19e-05 | 194 | 138 | 6 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.28e-05 | 195 | 138 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.28e-05 | 195 | 138 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 195 | 138 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 198 | 138 | 6 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 198 | 138 | 6 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 198 | 138 | 6 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 200 | 138 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-05 | 123 | 138 | 5 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.63e-05 | 144 | 138 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 150 | 138 | 5 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 151 | 138 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 151 | 138 | 5 | ced4f7ee377a23a804ae6fde624e8b55b79f1fd8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 151 | 138 | 5 | b52bb3b88e9a6473f571053537b8beb418678539 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 156 | 138 | 5 | f894fac4e44a23718b20ad80c9677bf4f2118002 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.26e-04 | 156 | 138 | 5 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 156 | 138 | 5 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 157 | 138 | 5 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.37e-04 | 159 | 138 | 5 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.37e-04 | 159 | 138 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | severe_influenza-B_cell|World / disease group, cell group and cell class (v2) | 1.48e-04 | 86 | 138 | 4 | 7b595bcba4bcb72b7de7c06e19f690f0c739c529 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 163 | 138 | 5 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 167 | 138 | 5 | 1bd0aa7a3c8649f342bb856cf861c4c5984ad889 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 167 | 138 | 5 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 167 | 138 | 5 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 169 | 138 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 169 | 138 | 5 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 170 | 138 | 5 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 171 | 138 | 5 | 7c8304573b892ef9ea4e048cba9ea9fbab848dcd | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.93e-04 | 171 | 138 | 5 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 174 | 138 | 5 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-04 | 174 | 138 | 5 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-04 | 174 | 138 | 5 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-04 | 175 | 138 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 175 | 138 | 5 | 78a86cac3e6c0d115c997d1c29ee0e24af54551f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-04 | 175 | 138 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 176 | 138 | 5 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 177 | 138 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 2.38e-04 | 179 | 138 | 5 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-04 | 180 | 138 | 5 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-04 | 180 | 138 | 5 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-04 | 180 | 138 | 5 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 181 | 138 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 181 | 138 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.51e-04 | 181 | 138 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 181 | 138 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.57e-04 | 182 | 138 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.57e-04 | 182 | 138 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-04 | 182 | 138 | 5 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-04 | 182 | 138 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-04 | 182 | 138 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 183 | 138 | 5 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.64e-04 | 183 | 138 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-04 | 183 | 138 | 5 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-04 | 183 | 138 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| Disease | Microvillus inclusion disease | 1.96e-05 | 2 | 131 | 2 | C0341306 | |
| Disease | urinary pH measurement | 1.94e-04 | 5 | 131 | 2 | EFO_0010136 | |
| Disease | Cerebellar Ataxia | 1.94e-04 | 5 | 131 | 2 | C0007758 | |
| Disease | Uterine leiomyoma | 7.36e-04 | 91 | 131 | 4 | HP_0000131 | |
| Disease | Optic Atrophy | 8.60e-04 | 10 | 131 | 2 | C0029124 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.25e-03 | 12 | 131 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth Disease | 1.25e-03 | 12 | 131 | 2 | C0007959 | |
| Disease | body weight | ZCCHC12 RPS6KA5 TEX11 VIRMA ADGRG6 RAB33A IPO9 CEP120 RTL3 DNM3 SENP6 PATJ CADPS2 PLXNA1 | 1.47e-03 | 1261 | 131 | 14 | EFO_0004338 |
| Disease | Cholestasis | 1.49e-03 | 110 | 131 | 4 | C0008370 | |
| Disease | Malformations of Cortical Development | 1.72e-03 | 14 | 131 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.72e-03 | 14 | 131 | 2 | C0431380 | |
| Disease | sulfate measurement | 1.72e-03 | 14 | 131 | 2 | EFO_0007864 | |
| Disease | Drug habituation | 1.75e-03 | 115 | 131 | 4 | C0013170 | |
| Disease | Drug abuse | 1.75e-03 | 115 | 131 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.75e-03 | 115 | 131 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.75e-03 | 115 | 131 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.75e-03 | 115 | 131 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.75e-03 | 115 | 131 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.75e-03 | 115 | 131 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.75e-03 | 115 | 131 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.75e-03 | 115 | 131 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.81e-03 | 116 | 131 | 4 | C0740858 | |
| Disease | neuroblastoma | 1.81e-03 | 116 | 131 | 4 | EFO_0000621 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.55e-03 | 17 | 131 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | skin pigmentation | 3.62e-03 | 69 | 131 | 3 | EFO_0003784 | |
| Disease | activities of daily living score measurement | 3.89e-03 | 21 | 131 | 2 | EFO_0008451 | |
| Disease | Intellectual Disability | 3.90e-03 | 447 | 131 | 7 | C3714756 | |
| Disease | Colorectal Carcinoma | 4.19e-03 | 702 | 131 | 9 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKDYNILTRITQLGI | 421 | Q9HBW9 | |
| QRIYSLEQLLQEAVL | 1951 | Q9P281 | |
| YQSLLTKNKARVIIL | 141 | P07550 | |
| LIAQSLLEKQQIYLE | 826 | Q6ZSZ5 | |
| LRKANSVLLVVQKVY | 286 | Q86UK0 | |
| YIRVAVSLRNQKVIL | 146 | Q86SQ4 | |
| IYKQGINIRLDTTLI | 251 | Q8N6S4 | |
| NYANVELILDIAKRI | 186 | Q13085 | |
| VFQELKVLEVLLLYN | 136 | Q86SJ2 | |
| RAQILIYAILQALDL | 216 | Q5VUY0 | |
| NVLYEKVALLLTNLE | 566 | Q32M45 | |
| INVVLVRIILLSYGK | 311 | O95450 | |
| IVKLQVINLAAKLYL | 536 | Q13367 | |
| LRRKYLTQVDILLQG | 146 | Q8NCD3 | |
| LDGIIILYTILELQK | 631 | Q68CQ1 | |
| SSLDQYVQIRIFKII | 26 | Q14088 | |
| LLAKIDNELVVRAYT | 56 | Q6BCY4 | |
| VLIQYLEKVLEKINS | 831 | Q5JSJ4 | |
| YIQLLIREKHTNLIA | 576 | P57740 | |
| GKLQRAIVSILNYVI | 211 | Q8IXQ6 | |
| SNNYRIVKEILIRLS | 1176 | Q14571 | |
| ILEILQFILNVRLDY | 971 | Q14573 | |
| NELEKIIAELLYSLQ | 1021 | O94822 | |
| TIIDILEYSNKKRLQ | 156 | Q9NUD7 | |
| ILVVSYVIILRSLKN | 211 | Q96R67 | |
| LQVLIVDYLKGLSVN | 916 | Q9NU22 | |
| LYTQQKVEILTALRK | 126 | Q8WZA0 | |
| VYELTNLLRQLDFKV | 366 | Q9UDY8 | |
| IVLAILELLKYHQRV | 156 | Q13547 | |
| RLQQLATLIQKIYRG | 696 | Q9UBC5 | |
| YIAIVIATNEKLRSL | 851 | P59045 | |
| KQRLVILERYFIALN | 141 | O95714 | |
| LQQELITNELAYKIL | 1876 | Q03001 | |
| LQAESRQLVDLYKVL | 756 | Q99665 | |
| LLNETKYRKVLQLQI | 2076 | Q5CZC0 | |
| TKDQVLLLIDIQVSY | 471 | Q9UQ16 | |
| IRLYLQELITITQKA | 1521 | Q5VYK3 | |
| DKLIRQQIDYKTLTL | 1491 | Q9UIW2 | |
| DKLIRQQIDYKTLTL | 1466 | P51805 | |
| IYSLFNVISILIKQV | 291 | Q9HB15 | |
| SIQRAVYKDLVLLLQ | 41 | Q9H1Q7 | |
| KALQISTLEERLQIY | 266 | Q6N069 | |
| QRITKYQLLLKELLT | 1416 | O60229 | |
| LAYLRAIDVKILQQL | 66 | Q96LR2 | |
| LLYRVFIINNSLEKE | 201 | Q969J5 | |
| TVLANLKRVLLQITY | 676 | P24043 | |
| IKNYDSTTRIIIQIL | 436 | A8MYU2 | |
| LGIIYRDIKLENILL | 171 | O75582 | |
| LKNLIVLFADTLQVY | 401 | Q9Y2D4 | |
| LLSYIQIIQAILRIH | 216 | Q8NGC4 | |
| NLIYLKLDRNRIISI | 301 | Q7Z2Q7 | |
| VFLTAIALNRYLKVV | 181 | Q8TDS5 | |
| ILQEQLAESVYRALK | 1331 | P29475 | |
| LVILSYTNIIRTILK | 211 | A6NCV1 | |
| VVTNNQLLRVKYLLV | 256 | Q8N5Y8 | |
| VALVYIKRLLTSANI | 96 | P0C7X3 | |
| IIVTEKTNILLRYLH | 46 | Q9BW61 | |
| EIYNRKSVLLTLIAV | 1146 | Q13315 | |
| VLNRYLDIKEILQSL | 171 | P15812 | |
| QYQLLRCNVDLLKII | 61 | Q9UIV1 | |
| LARALAQYLVVVSKL | 2221 | P42858 | |
| RELLAALQKVVVPIY | 231 | Q8IWX8 | |
| GNILVVLVLVQYKRL | 51 | P32246 | |
| VEILRVYLALQSKLQ | 256 | Q8N960 | |
| VYLQDVKVLTLLLES | 461 | Q5SYB0 | |
| IKSRDLLALIQVYAE | 571 | Q9ULH1 | |
| RLDLQLHIYQLKTLI | 1221 | Q86UW7 | |
| LRIQQIIYCHKLTII | 76 | Q8NEE6 | |
| LAIIAQVLSYKEAVL | 26 | P49913 | |
| LAIRQLASVILKQYV | 71 | Q96P70 | |
| NYLRTLINELVKGIL | 4446 | Q14204 | |
| VYEAGKLNLLTVIQL | 296 | Q7Z4H7 | |
| QYQLLRCNVDLLKII | 61 | Q9UFF9 | |
| VDLRTQLVLYENALK | 321 | Q9Y613 | |
| YVVRLLELIAKSQLT | 121 | Q969P5 | |
| LVTYRNLINKLSVVD | 301 | Q9NQZ2 | |
| RRKVLILNYLQTAVS | 161 | Q4U2R8 | |
| VIVKAYLQVLSVLRD | 1916 | Q9NZJ4 | |
| TDVFLQIYKVLVLSR | 1701 | Q6ZTR5 | |
| LLIAKNTRLEIYVVT | 31 | Q16531 | |
| LVVKQEQLLRVALYL | 271 | Q92845 | |
| LVILSYTNIIRTILK | 211 | A6NL08 | |
| LLQQLLQYTVSKLQV | 266 | A6NGG8 | |
| NIVAQLKQLYRILQT | 431 | O14896 | |
| AASYIVLKLENEIRQ | 6 | Q8N8U3 | |
| YLTKDFEQLISIILR | 101 | Q9NYV6 | |
| ILKQYQTLREALVAA | 1246 | O14607 | |
| KNLLVNTLYTVRVAA | 1711 | Q92673 | |
| AKNFLVVVLQLYRLV | 291 | Q6ZUK4 | |
| YQALLLQVLEQIKFL | 3686 | Q8NF91 | |
| VQEAILARKEYASLI | 4666 | Q8NF91 | |
| ERKKLLSYIQRLVQI | 96 | Q9Y3Z3 | |
| YVNRVRLQELKALLL | 221 | Q96ER9 | |
| IQQINIELYRLFGIK | 211 | Q9NXP7 | |
| RLELLNIVEGIYQLK | 111 | Q9UMX6 | |
| LTFQIHLQELLQYKR | 166 | Q8NC44 | |
| VQLAYVQLIRSLLKE | 531 | Q7Z333 | |
| ILELNKVQLLYEQIG | 611 | Q9H0K1 | |
| RELLDQLQQKLYLIQ | 286 | Q9H5Q4 | |
| LVVRDVNTLQILQLY | 31 | Q9P2S5 | |
| RTEEALQLYNQIIKL | 241 | O76094 | |
| LLSVENTVIYRIQAL | 551 | P07225 | |
| VLLKLIRLAQFTIEY | 116 | Q86YF9 | |
| YQSQARKKLIIIIVL | 256 | Q13277 | |
| RLYDIILQNLVELLQ | 426 | Q9UHB9 | |
| LQLIKVTRLQYLNAL | 636 | Q8NE01 | |
| NIRAIYLTLEKLIQS | 161 | Q9BTX7 | |
| LQILLEKVAATLEYL | 341 | Q5VXH4 | |
| ATLSVIRDYLVQKLQ | 766 | Q9H270 | |
| NLQKYVREQILLAVA | 106 | Q9C0E2 | |
| LDLSVVLKAVYLVLN | 651 | Q8N2C7 | |
| LAKYLQLRNVIERLQ | 46 | Q9UBK9 | |
| LLFETRDISLIKQYV | 2876 | O60673 | |
| VLNKQLTYVLLDIVI | 911 | Q9Y5W7 | |
| AVLQITKIIYSTLLQ | 401 | Q96AG3 | |
| LLKNAYGRIILQVVA | 1746 | Q8NI35 | |
| NQLLERSLKVYIKTV | 426 | P58005 | |
| LQILLEKVAATLEYL | 341 | Q5TYX0 | |
| IVYLLSRLFLVNKLV | 901 | Q3MJ13 | |
| KILSYNRANRVVAIL | 451 | Q969P6 | |
| QAAVASLEQLYVKLI | 146 | Q8IYF3 | |
| VNKLTNLEEQYIILI | 536 | Q9GZR1 | |
| DIVISKLTQILSYLR | 276 | Q13123 | |
| YLTKDFEQLISIILR | 101 | A6NIE6 | |
| LLLYREQLVKILQRT | 691 | Q14997 | |
| DSLVKILQDYNLQIL | 741 | P49754 | |
| LREQLLVTIQKTFNY | 306 | Q7Z4N2 | |
| VLDQAVQIINYIKAR | 391 | Q49AG3 | |
| LDSQRLQYIITNVLK | 321 | Q8IX04 | |
| SLYVIRLEVQLQNAI | 146 | P0CG32 | |
| NSYSIKVVLQELRRL | 111 | Q15819 | |
| RLVDVVAVILKALTY | 436 | Q9BTW9 | |
| ILIRDKNALQNIILY | 551 | Q15063 | |
| FRRVQSLILDLKYVL | 471 | Q8IWV8 | |
| YQKLLELILLDQTVR | 531 | Q69YN4 | |
| KDYQRLLQTIAVLEA | 501 | Q8IYH5 | |
| SLYVIRLEVQLQNAI | 146 | Q6PEW1 | |
| VLEIQLQALDIRLSY | 2566 | Q5THJ4 | |
| VLSDLAIQIYQQLVR | 1601 | Q9Y4I1 | |
| DLSIQIYQQLIKIAE | 1596 | Q9ULV0 |